课题基金 / 基金详情

The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva

The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
批准号:
10150273
负责人:
Daniel S Perrien
金额:
$40.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-06-30

项目摘要

项目成果

Daniel S Perrien的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Fibrodysplasia ossificans progressiva (FOP) is a rare, currently untreatable, congenital disease in which skeletal muscle repair is redirected to endochondral bone formation (heterotopic ossification, HO). These pathologies cause pain, muscle destruction, and joint fusion, leading to progressive immobilization and eventually premature death. FOP is caused by a mutation in Alk2 (most commonly R206H) that renders the receptor sensitive to aberrant activation by Activin A (ActA). However, the “flares” that lead to HO appear to be initiated by inflammatory insults, and HO can be reduced in FOP mice by depletion of inflammatory innate immune cells including macrophages. Fibroadipoprogenitors (FAPs), residing in the muscle interstitium appear to be the critical precursors of chondrocytes in FOP. In healthy muscle repair, macrophages secrete TNFα to trigger apoptosis of FAPs at a precise and critical time in the repair process. However, in injured FOP muscles, FAPs survive and differentiate into chondrocytes, suggesting their interaction with macrophages is disrupted. Therefore, this proposal will explore the hypothesis that pro-inflammatory and anti-inflammatory macrophages are critical sources of cytokines that enable survival and expansion of the chondrogenic fibroadipoprogenitors in FOP. Specifically, it seeks to determine the critical source(s) of ActA and what signals pathways in FAPS are disrupted to block their normal apoptotic fate. These studies will be the first to explore the mechanisms by which macrophages interact with chondrogenic FAPs to support chondrogenesis and HO, and they will provide critical insights to the early stages of FOP flares.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
  • 批准号:
    10434101
  • 项目类别:
  • 资助金额:
    $41.94万
  • 财政年份:
    2019
  • 负责人:
    Daniel S Perrien
  • 依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
  • 批准号:
    10249238
  • 项目类别:
  • 资助金额:
    $42.39万
  • 财政年份:
    2019
  • 负责人:
    Daniel S Perrien
  • 依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
  • 批准号:
    10168215
  • 项目类别:
  • 资助金额:
    $9.84万
  • 财政年份:
    2019
  • 负责人:
    Daniel S Perrien
  • 依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
  • 批准号:
    10407678
  • 项目类别:
  • 资助金额:
    $11.81万
  • 财政年份:
    2019
  • 负责人:
    Daniel S Perrien
  • 依托单位:
国内基金
海外基金
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
  • 批准号:
    82372202
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯旭敏
  • 依托单位:
Innate-likeB细胞受损介导凋亡细胞的清除障碍在系统性红斑狼疮发病中的作用及机制研究
  • 批准号:
    81860295
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2018
  • 负责人:
    张伟
  • 依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究